BiondVax Pharmaceuticals Ltd. ( BVXV) - Stock Earnings

BVXV Quarterly earnings

DateEarningsRevenue
2022Q1 -9.4 million USD 0 USD
2022Q2 -12.9 million USD 0 USD
2022Q3 3.7 million USD 0 USD

BVXV Yearly earnings

DateEarningsRevenue
2020 -4.5 million USD 0 USD
2021 -40.0 million USD 0 USD
2022 -5.8 million USD 0 USD

BVXV

Price: $1.36

52 week price:
1.27
16.01

Earnings Per Share: -2.55 USD

P/E Ratio: -0.95

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Israel

Volume: 88400

Ebitda: 416918

Market Capitalization: 6.3 million

Links: